Kristin J Redmond

Jan 11, 2024 | redjournal.org | Eric J. Lehrer |Daniel M. Trifiletti |Simon Lo |Kristin J Redmond

ABSTRACT There is limited data available on clinical outcomes following stereotactic body radiation therapy (SBRT) for non-spinal bone metastases. We performed a systematic review and meta-analysis to characterize local control (LC), overall survival (OS), pain response rates, and toxicity following SBRT. Primary outcomes were 1-year LC, incidences of acute and late Grade 3-5 toxicities, and overall pain response rate at 3 months. The secondary outcome was 1-year OS.